COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Intragastric Balloon Market would witness market growth of 12% CAGR during the forecast period (2020-2026).
The cost-effectiveness and safety of intragastric balloons would play an important role in market growth. The treatments for intragastric balloon implantation are safer and lower-cost alternatives to bariatric surgery, which is an invasive weight loss procedure that causes multiple risks after surgery. The cost of these procedures is also considerably higher than the intragastric balloons plantation. Therefore, non-surgical and less-invasive weight loss procedures such as intragastric balloon implantation are becoming increasingly common.
Vendors’ growing concentration on technical developments, which is one of the key intragastric balloon industry trends, will also drive market growth. Different leading vendors concentrate on improving the capabilities and performance of intragastric balloon devices. The manufacturers also focus on balloon volume changes and longer implantation time. Minimally-invasive procedures are required for the implantation of the intragastric balloon, which can be conveniently carried out in an ambulatory environment. A single endoscopic procedure can be used to position an intragastric balloon, and it is easily reversible.
In 2018, France’s intragastric balloons market recorded a substantial market share due to increased demand for weight-loss procedures. According to the OECD, one in ten people is obese and in France, 40 percent is overweight. Strong demand for weight-loss strategies as a result of rising obesity prevalence would stimulate potential business growth.
Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil
Scope of the Study
Market Segmentation:
By Administration

  • Endoscopy and
  • Pill Form


By Type

  • Single
  • Dual and
  • Triple


By Filling Material

  • Gas Filled and
  • Saline Filled


By End Use

  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free